Trial Profile
Phase II Study of Novel Epothilone (BMS-247550) in Patients With MBC Who Are Refractory to an Anthracycline, a Taxane, and Capecitabine.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2017
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 23 Aug 2010 New trial record